Massar Capital Management, LP Exagen Inc. Transaction History
Massar Capital Management, LP
- $89.5 Billion
- Q1 2025
A detailed history of Massar Capital Management, LP transactions in Exagen Inc. stock. As of the latest transaction made, Massar Capital Management, LP holds 20,840 shares of XGN stock, worth $123,998. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,840Holding current value
$123,998% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
39Shares Held
6.16MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$9 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$5.3 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.16 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.92 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$2.89 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $96.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...